AMGN Amgen PE ratio, current and historical analysis
The current PE ratio for Amgen stock as of Apr 21, 2025 is 35.92. This is calculated based on the current EPS of $7.62 and the stock price of $273.68 per share. The P/E ratio has a decrease of 15% from the past four quarters average of 42.2.
AMGN PE ratio history
The average historical PE ratio of Amgen for the last ten years is 24.4. The current PE ratio of 35.92 is 47% above the historical average. Over the past ten years, AMGN's PE ratio was at its highest in the Dec 2017 quarter at 64.17, when the stock price was $173.9 and the EPS was $2.71. The lowest value was in the Dec 2016 quarter, when it reached 14.17 with a price of $146.21 and an EPS of $10.32.
Amgen PE ratio by year
Maximum annual increase: 352.86% in 2017
Maximum annual decrease: -76.11% in 2018
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2024 | 34.2 | 49.15% | $260.64 | $7.62 |
| 2023 | 22.93 | 6.35% | $288.02 | $12.56 |
| 2022 | 21.56 | -0.92% | $262.64 | $12.18 |
| 2021 | 21.76 | 17.37% | $224.97 | $10.34 |
| 2020 | 18.54 | -0.32% | $229.92 | $12.4 |
| 2019 | 18.6 | 21.33% | $241.07 | $12.96 |
| 2018 | 15.33 | -76.11% | $194.67 | $12.7 |
| 2017 | 64.17 | 352.86% | $173.9 | $2.71 |
| 2016 | 14.17 | -20.12% | $146.21 | $10.32 |
| 2015 | 17.74 | -24.29% | $162.33 | $9.15 |
| 2014 | 23.43 | 38.64% | $159.29 | $6.8 |
| 2013 | 16.9 | 9.95% | $114.08 | $6.75 |
| 2012 | 15.37 | -2.6% | $86.2 | $5.61 |
| 2011 | 15.78 | 38.54% | $64.21 | $4.07 |
| 2010 | 11.39 | -8.81% | $54.9 | $4.82 |
Amgen PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Dec 2024 | 34.2 | -16.26% | $260.64 | $7.62 |
| Sep 2024 | 40.84 | -23.53% | $322.21 | $7.89 |
| Jun 2024 | 53.41 | 32.24% | $312.45 | $5.85 |
| Mar 2024 | 40.39 | 76.14% | $284.32 | $7.04 |
| Dec 2023 | 22.93 | 20.75% | $288.02 | $12.56 |
| Sep 2023 | 18.99 | 27.71% | $268.76 | $14.15 |
| Jun 2023 | 14.87 | -8.88% | $222.02 | $14.93 |
| Mar 2023 | 16.32 | -24.3% | $241.75 | $14.81 |
| Dec 2022 | 21.56 | 19.78% | $262.64 | $12.18 |
| Sep 2022 | 18 | -12.49% | $225.4 | $12.52 |
| Jun 2022 | 20.57 | -13.39% | $243.3 | $11.83 |
| Mar 2022 | 23.75 | 9.15% | $241.82 | $10.18 |
| Dec 2021 | 21.76 | -0.05% | $224.97 | $10.34 |
| Sep 2021 | 21.77 | -11.58% | $212.65 | $9.77 |
| Jun 2021 | 24.62 | 20.33% | $243.75 | $9.9 |
AMGN average PE ratio chart
AMGN's current P/E ratio is above the 3, 5 and 10-year historical averages.
AMGN PE vs peers
AMGN's PE ratio is lower than its peer stocks LLY and ABBV, but it is greater than JNJ's and ABT's. Amgen is presently trading at a higher PE ratio (35.92) than its peer group average of 35.03.
| Stock name | PE ratio | Market cap |
|---|---|---|
| BIIB Biogen Inc | 10.52 | $17.26B |
| PFE Pfizer Inc | 15.72 | $126.52B |
| ABT Abbott Laboratories | 17.07 | $227.09B |
| JNJ Johnson & Johnson | 26.84 | $377.37B |
| AMGN Amgen Inc | 36.17 | $148.08B |
| LLY ELI LILLY & Co | 69.52 | $775.13B |
| ABBV AbbVie Inc | 71.77 | $304.08B |
| GILD Gilead Sciences Inc | 277.87 | $131.5B |
| BMY Bristol Myers Squibb Co | N/A | $100.02B |
| ILMN Illumina Inc | N/A | $11.61B |
Frequently asked questions
What is Amgen's PE ratio?
AMGN's price to earnings ratio is 35.92 as of Apr 21, 2025.
What is the 3-year average PE ratio for Amgen (AMGN)?
Over the last 3 years, the average price to earnings ratio for AMGN stock is 27.46.
What is the 5-year average PE ratio for Amgen (AMGN)?
Over the last 5 years, the average price to earnings ratio for AMGN stock is 24.87.
What is the highest PE ratio for AMGN?
In the last ten years, the Dec 2017 quarter recorded the highest quarterly PE ratio at 64.17.
How does the current PE ratio for AMGN compare to its historical average?
The current price to earnings ratio of AMGN is 47% higher than the 10-year historical average.
How is AMGN's PE ratio calculated (Amgen PE ratio formula)?
The PE ratio is calculated by dividing the most recent price of a stock by its trailing twelve months EPS. As of today (Apr 21, 2025), Amgen's stock price is $273.68. The earnings per share for the trailing twelve months (TTM) ending Dec 2024 is $7.62. Therefore, Amgen's P/E ratio for today is 35.92. PE RATIO(35.92) = STOCK PRICE($273.68) / TTM EPS($7.62)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from 
and Sharadar.